- Home
- IFS vs RNA Comparison
IFS vs RNA Comparison
Compare IFS & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFS
- RNA
- Stock Information
- Founded
- IFS 1897
- RNA 2012
- Country
- IFS Peru
- RNA United States
- Employees
- IFS N/A
- RNA N/A
- Industry
- IFS Commercial Banks
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- IFS Finance
- RNA Health Care
- Exchange
- IFS Nasdaq
- RNA Nasdaq
- Market Cap
- IFS 3.3B
- RNA 3.4B
- IPO Year
- IFS 2019
- RNA 2020
- Fundamental
- Price
- IFS $34.51
- RNA $28.69
- Analyst Decision
- IFS Buy
- RNA Strong Buy
- Analyst Count
- IFS 1
- RNA 12
- Target Price
- IFS $30.00
- RNA $68.25
- AVG Volume (30 Days)
- IFS 177.8K
- RNA 1.5M
- Earning Date
- IFS 05-08-2025
- RNA 05-20-2025
- Dividend Yield
- IFS 2.90%
- RNA N/A
- EPS Growth
- IFS 21.96
- RNA N/A
- EPS
- IFS 3.02
- RNA N/A
- Revenue
- IFS $1,189,396,011.00
- RNA $10,897,000.00
- Revenue This Year
- IFS N/A
- RNA N/A
- Revenue Next Year
- IFS $7.58
- RNA $135.33
- P/E Ratio
- IFS $11.44
- RNA N/A
- Revenue Growth
- IFS 9.69
- RNA 13.98
- 52 Week Low
- IFS $21.33
- RNA $21.51
- 52 Week High
- IFS $34.60
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- IFS 64.14
- RNA 47.66
- Support Level
- IFS $34.25
- RNA $25.58
- Resistance Level
- IFS $35.32
- RNA $33.62
- Average True Range (ATR)
- IFS 0.86
- RNA 2.15
- MACD
- IFS 0.28
- RNA -0.23
- Stochastic Oscillator
- IFS 82.88
- RNA 38.72
About IFS Intercorp Financial Services Inc.
Intercorp Financial Services Inc is a provider of financial services through banking, insurance, and wealth management businesses, as well as the recent integration of Izipay enhancing its payments ecosystem. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services, and Payments segment provides administration services, operation and processing of credit and debit cards. Its geographical segments include Peru and Panama.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.